HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Masafumi Natsuaki Tsuyoshi Itoh Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Sakao, Y. Articles by Itoh, T. Search for Related Content PubMed PubMed Citation Articles by Sakao, Y. Articles by Itoh, T. Related Collections Lung - cancer

Eur J Cardiothorac Surg 2004;25:520-522
© 2004 Elsevier Science NL

Carcinoembryonic antigen as a predictive factor for postoperative tumor relapse in early-stage lung adenocarcinoma

Department of Thoracic and Cardiovascular Surgery, Saga Medical School of the University, Nabesima, 5-1-1, Saga 849-8501, Japan

Received 5 October 2003; received in revised form 13 January 2004; accepted 19 January 2004.

^* Corresponding author. Tel.: +81-952-34-2345; fax: +81-952-34-2061
e-mail: sakao{at}post.saga-med.ac.jp

Objectives: To clarify the usefulness of measuring serum carcinoembryonic antigen (CEA) preoperatively to detect patients who will have a poor outcome after surgery, and who cannot be selected by conventional staging modalities. Methods: One hundred patients with adenocarcinoma of the lung underwent standard surgical procedures between 1994 and April 2001 at our institution. Preoperative staging was assessed according to the TNM classification of the International Union Against Cancer. The associations between preoperative serum CEA level and the postoperative recurrence or lymph node metastasis were examined. The serum CEA level was classified into two groups according to concentration of CEA level: low (normal) CEA (5.0 ng/ml) and high CEA (>5.0 ng/ml). Results: The high CEA level was associated with tumor relapse (P=0.01). According to the preoperative staging, the increased CEA was associated with tumor relapse only in stage C-IA (P=0.001). Stage C-IB and more advanced stages did not show an association between increased CEA and tumor relapse. In C-IA, risk for lymph node involvement was significantly higher in the high CEA group (4/9; 44.4%) than in the low CEA group (6/47; 12.8%, P=0.03). Furthermore, the rate of tumor relapse in C-IA-pN0 was significantly higher in the high CEA group (4 of the 5, 80%) than in the low CEA group (9 of the 41, 22.0%, P=0.018). The 5-year disease-free survival rate for patients with a high serum CEA level (N=9) was 22.2%, and 75.0% for patients with a normal CEA (N=47) level (P=0.0004). Conclusions: Increased serum CEA is an important predictive factor for poor outcome after surgery in early-stage (C-IA) lung adenocarcinoma.

Key Words: Clinical IA • Carcinoembryonic antigen • Predictive factor

This article has been cited by other articles:

				T. Tsuchiya, S. Hashizume, S. Akamine, M. Muraoka, S. Honda, K. Tsuji, S. Urabe, T. Hayashi, N. Yamasaki, and T. Nagayasu Upstaging by Vessel Invasion Improves the Pathology Staging System of Non-Small Cell Lung Cancer Chest, July 1, 2007; 132(1): 170 - 177. [Abstract] [Full Text] [PDF]